| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.05 | 0.3 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.3 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |